NGNE Neurogene Inc.
$35.48▼ -1.77%
Healthcare
Other
After hours
$35.48▲ +0.00%
Sep 11, 7:30 PM ET
Volume 181.2K
Avg Volume (10D) 185.0K
Key Metrics & Fundamentals
Market Cap
$710.00M
P/E Ratio
–
Div Yield
–%
52W Range
15.93 - 43.66
% vs 50 MA
-3.50%
% vs 200 MA
34.11%
RSI-14
44.1
MACD Histogram
-0.3500
Beta (1Y vs SPY)
1.56
Free Cash Flow
-$24.12M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$33.67M
COGS
–
Operating Exp
$36.67M
Operating Income
-$36.67M
EBIT
-$36.67M
Pretax Income
-$34.49M
Net Income
-$34.49M
EPS (Diluted)
-1.53
Price & Volume History
Loading chart…
Recent News
Neurogene to Participate in H.C. Wainwright 28th Annual Global Investment Conference
Business Wire · Sep 8, 2026 11:30 AM
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire · Sep 4, 2026 8:01 PM
Neurogene: Q2 Earnings Snapshot
Associated Press · Aug 11, 2026 11:36 AM
Neurogene Reports Second Quarter 2026 Financial Results and Highlights Recent Updates
Business Wire · Aug 11, 2026 11:30 AM
Neurogene Prices $125 Million Public Offering
MT Newswires · Jul 1, 2026 11:51 AM
Neurogene Inc. Announces Pricing of $125 Million Public Offering
Business Wire · Jul 1, 2026 11:00 AM
Neurogene Launches Public Offering
MT Newswires · Jun 30, 2026 8:25 PM
Neurogene Inc. Announces Proposed Public Offering
Business Wire · Jun 30, 2026 8:01 PM
Neurogene Reports Positive Long-term Clinical Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome
Business Wire · Jun 29, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See NGNE's money flow as a full page
Social Sentiment
No Reddit posts found for NGNE.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.